ArticleJournal of clinical microbiology2007
Spoligotype signatures in the Mycobacterium tuberculosis complex.
Article in Journal of clinical microbiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 53 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
53 citing papers in PubMed, 114 citations in OpenAlex.
- Trial
- Evaluating sensitivity and specificity of the DPP Vet TB assay in badgers using Bayesian latent class models.PloS one · 2025Article
- Comparative Transcriptomics Reveal Differential Expression of Coding and Non-Coding RNAs in Clinical Strains ofInternational journal of molecular sciences · 2024Article
- Distribution and Clonality of drug-resistant tuberculosis in South Africa.BMC microbiology · 2021Article
- A Bayesian analysis of a Test and Vaccinate or Remove study to control bovine tuberculosis in badgers (Meles meles).PloS one · 2021Article
- Exploring the usefulness of molecular epidemiology of tuberculosis in Africa: a systematic review.International journal of molecular epidemiology and genetics · 2020Review
- Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB Therapy.Frontiers in cellular and infection microbiology · 2020Article
- Article
- New insights into the transposition mechanisms of IS6110 and its dynamic distribution between Mycobacterium tuberculosis Complex lineages.PLoS genetics · 2018Article
- Biology of clinical strains of Mycobacterium tuberculosis with varying levels of transmission.Tuberculosis (Edinburgh, Scotland) · 2018Article
- Article
- Diversity ofBioMed research international · 2018Article
- Genetic diversity and potential routes of transmission of Mycobacterium bovis in Mozambique.PLoS neglected tropical diseases · 2018Article
- Mycobacterial genomic DNA from used Xpert MTB/RIF cartridges can be utilised for accurate second-line genotypic drug susceptibility testing and spoligotyping.Scientific reports · 2017Article
- Article
- From Evolutionary Advantage to Disease Agents: Forensic Reevaluation of Host-Microbe Interactions and Pathogenicity.Microbiology spectrum · 2017Review
- A Genomic Signature for Genotyping Mycobacterium tuberculosis.Bioinformation · 2017Article
- Molecular identification ofEuropean academic research · 2016Article
- Epidemiologic Correlates of Pyrazinamide-Resistant Mycobacterium tuberculosis in New York City.Antimicrobial agents and chemotherapy · 2015Article
- A microbiological revolution meets an ancient disease: improving the management of tuberculosis with genomics.Clinical microbiology reviews · 2015Review
Corrections and comments
- Erratum issued
Authors and funding
7 authors at 2 institutions in 2 countries.
Funding
Abstract
Evolution of the direct repeat region in Mycobacterium tuberculosis has created unique spoligotype signatures specifically associated with IS6110-defined strain families. Spoligotyping signatures may enable the analysis of the strain population structure in different settings and will enable the rapid identification of strain families that acquire drug resistance or escape protective immunity in drug and vaccine trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.